Stefanos Aivazidis, PhD
Associate
Stefanos Aivazidis is an Associate at Rhea Venture Partners. Holding a PhD in Toxicology and board certifications as a Diplomate of the American Board of Toxicology (DABT) and European Registered Toxicologist (ERT), he brings extensive experience in nonclinical drug development and translational science. Before joining Rhea Venture Partners, Stefanos served as a Senior Scientist in Toxicology at AbbVie and Cerevel Therapeutics, and held research positions at Sanofi, Northwestern University and the University of Colorado. At Rhea, Stefanos combines deep scientific expertise with a structured analytical approach to evaluate investment opportunities and support scientific due diligence.
